A pharmaceutical company wants to study the effectiveness of a new drug in treating migraine headaches. For its trial, it gathers randomly selected volunteers regardless of their age, gender, or race. Is this an appropriate, random sample on which the pharmaceutical company can rely to draw its conclusions?(1 point)

Question

Responses

No, this is not an appropriate, random sample. The company should only run the trial on female volunteers because migraine headaches are more common in women.
No, this is not an appropriate, random sample. The company should only run the trial on female volunteers because migraine headaches are more common in women.

No, this is not an appropriate, random sample. The company should only run the trial on volunteers age 50 and older.
No, this is not an appropriate, random sample. The company should only run the trial on volunteers age 50 and older.

There is not enough information to determine whether this is an appropriate, random sample for the population in this scenario.
There is not enough information to determine whether this is an appropriate, random sample for the population in this scenario.

Yes, this is an appropriate, random sample.
Yes, this is an appropriate, random sample.
Skip to navigation

Answer 1

The most accurate response would be:

There is not enough information to determine whether this is an appropriate, random sample for the population in this scenario.

While randomly selecting volunteers is a good practice, the effectiveness of the drug could be influenced by various factors including age, gender, and possibly other health conditions. A more detailed understanding of these factors and how they relate to migraines would be necessary to determine if the sample is indeed appropriate for drawing conclusions about the drug’s effectiveness.